A concise and selective synthesis of novel 5-aryloxyimidazole NNRTIs.

Autor: Jones LH; Sandwich Laboratories, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK. lyn.jones@pfizer.com, Dupont T, Mowbray CE, Newman SD
Jazyk: angličtina
Zdroj: Organic letters [Org Lett] 2006 Apr 13; Vol. 8 (8), pp. 1725-7.
DOI: 10.1021/ol060316x
Abstrakt: [reaction: see text] A concise and efficient route to the construction of a 5-aryloxyimidazole has been developed. The key step was the selective O-arylation of a 2,4-dimethoxybenzyl-protected imidazolone. The final compound is a potent inhibitor of HIV reverse transcriptase.
Databáze: MEDLINE